AFT results announcement May 24 2021

4 May 2021


AFT Pharmaceuticals to announce full year results on Monday May 24 2021


AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to
release on Monday May 24 2021 its full year results for the year ended March
31 2021. The release will be issued at around 09:00.

This will be followed by a presentation by management at 10:00 by
teleconference. The presentation material which will be referred to by
management will be issued at around 09:00 and will also be available on the
company’s website aftpharm.com.

To attend the conference call you will need to use the pre-registration link
below. Once you have completed this you will be provided with dial in details
and a unique pin code.

Registration Link: https://s1.c-conf.com/diamondpass/10013405-dr10v3.html


For and on behalf of AFT Pharmaceuticals Limited, Malcolm Tubby, CFO.

For more information:


Investors Media
Malcolm Tubby Richard Inder
CFO, AFT Pharmaceuticals Ltd The Project
Phone: +64 9 488 0232 Phone: 021 645 643
Email: malcolm@aftpharm.com Email: richard@theproject.co.nz




About AFT Pharmaceuticals
AFT is a growing multinational pharmaceutical company that develops,
markets and distributes a broad portfolio of pharmaceutical products across a
wide range of therapeutic categories which are distributed across all major
pharmaceutical distribution channels: over-the-counter (OTC), prescription
and hospital. Our product portfolio comprises both proprietary and in-licensed
products, and includes patented, branded and generic drugs. Our business

model is to develop and in-license products for sale by our own dedicated
sales teams in our home markets of Australia and New Zealand and in certain
Southeast Asian markets, and to out-license our products to local licensees
and distributors to the rest of the world. For more information: aftpharm.com